Apolipoprotein E (apoE)-induced activation of low-density lipoprotein receptor (LDL) family members reduces inflammatory responses by suppressing c-Jun N-terminal kinase (JNK) activation. We aimed to identify which specific receptor family member mediates the effect of apoE on inflammation in primary cultures of microglia. Low-density lipoprotein receptor-related protein 1 (LRP1)-deficient (LRP1−/−) microglia were derived from mice using tissue-specific loxP/Cre recombination. Using a peptide formed from the receptor-binding region of apoE (EP), we found that LRP1 mediates the effects of apoE on microglial inflammation. Microglial LRP1 was also essential for EP to suppress JNK activation induced by lipopolysaccharide.
Introduction
Inflammation in the brain is characterized by activated microglial cells and increased levels of cytokines and chemokines. Activated microglia undergo morphological changes and become phagocytic, removing foreign particles and neurotoxic agents (Ladeby et al., 2005) . Chronic activation of microglia can lead to overproduction of various neurotoxic molecules such as nitric oxide (NO), reactive oxygen species, excitotoxins, and pro-inflammatory cytokines that lead to neuronal death (Boje and Arora, 1992; Combs et al., 2001; Meda et al., 1995) . Regulating microglial activation is a target for overcoming inflammation and neurodegeneration in the brain.
Apolipoprotein E (apoE), a 34 kDa protein that transports lipids, modulates the inflammatory response of microglia. ApoE is synthesized in the central nervous system (CNS) primarily by astrocytes and microglia. Single nucleotide polymorphisms in the APOE gene result in three common protein isoforms, termed apoE2, apoE3, and apoE4. These isoforms differ by the amino acids at residues 112 and 158 (Weisgraber, 1994) . The APOE ε4 allele increases an individual's risk for Alzheimer's disease, which includes a dramatic increase in brain inflammation (Bales et al., 2000; McGeer and McGeer, 2001a, 2001b) . In an isoform-dependent manner, apoE reduces CNS inflammation, with apoE4 displaying the least anti-inflammatory activity. Several small apoE mimetic peptides have been developed which reduce glial inflammation (Laskowitz et al., 1997 (Laskowitz et al., , 2000 (Laskowitz et al., , 1998 (Laskowitz et al., , 2001 Lynch et al., 2001 Lynch et al., , 2003 Mace et al., 2007; Pocivavsek et al., 2009) .
ApoE modulates microglial inflammation through activation of the low-density lipoprotein (LDL) receptor family (Moon et al., 2007; Pocivavsek et al., 2009 ). The LDL receptor family includes the lowdensity lipoprotein receptor (LDLR), very-low-density lipoprotein receptor (VLDLR), apolipoprotein E receptor 2 (ApoEr2), and the LDL receptor-related protein-1 (LRP1). Neuronal receptors (ApoEr2, VLDLR, and LRP1) (Christie et al., 1996; Kim et al., 1996; Rebeck et al.,1993) have been implicated in neurite outgrowth, calcium homeostasis, kinase activation and cell migration (Beffert et al., 2004) . A different subset of receptors are expressed on astrocytes and microglia: LDLR, LRP1, and VLDLR (Christie et al., 1996; Rebeck et al., 1993) . ApoE signaling through these receptors involves mitogen-activated protein kinase (MAPK) pathways in neurons and glia (Hoe et al., 2005 (Hoe et al., , 2006 Pocivavsek et al., 2009 ). However, it has not been determined whether all or some of LDL receptor family members expressed in microglia modulate the inflammatory response.
MAPK signaling pathways have been demonstrated in microglia activated with endotoxin lipopolysaccharide (LPS) (Bhat et al., 1998; Han et al., 2002; Pyo et al., 1998; Xie et al., 2004) . In our previous study, we demonstrated that LDL receptor family activation modulates glial Journal of Neuroimmunology 214 (2009) [25] [26] [27] [28] [29] [30] [31] [32] 
